Greenbio Group produces high-quality, dependable, clinically validated medicines and medicinal-grade supplements for human and animal use, including products developed to treat selected specific health conditions. The group also utilises vertical systems and limited-space indoor technology to optimise urban farming and food production. Greenbio Group will play a key role in CRC projects under Research Program 2, high-tech indoor cropping solutions; and Program 3, adding value.